Apogee Therapeutics Inc (APGE)

Cost of Revenue

$408.00K

TTM · Period ending: · USD

APGE logo

APGE Cost of Revenue

Latest reported$408.00K
APGE TTM Cost of Revenue ($0.00 → $408.00K)
High-resolution chart · PNG

APGE cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Apogee Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
408,000
408,000
0
400,000
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.